423 related articles for article (PubMed ID: 27818134)
21. Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.
Sadria R; Motamed N; Saberi Anvar M; Mehrabani Yeganeh H; Poopak B
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1757. PubMed ID: 36411516
[TBL] [Abstract][Full Text] [Related]
22. The significance of spliceosome mutations in chronic lymphocytic leukemia.
Rozovski U; Keating M; Estrov Z
Leuk Lymphoma; 2013 Jul; 54(7):1364-6. PubMed ID: 23270583
[TBL] [Abstract][Full Text] [Related]
23.
Aptullahoglu E; Wallis JP; Marr H; Marshall S; Bown N; Willmore E; Lunec J
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511096
[TBL] [Abstract][Full Text] [Related]
24. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
Rasi S; Khiabanian H; Ciardullo C; Terzi-di-Bergamo L; Monti S; Spina V; Bruscaggin A; Cerri M; Deambrogi C; Martuscelli L; Biasi A; Spaccarotella E; De Paoli L; Gattei V; Foà R; Rabadan R; Gaidano G; Rossi D
Haematologica; 2016 Apr; 101(4):e135-8. PubMed ID: 26819056
[No Abstract] [Full Text] [Related]
26. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
27. Acquired initiating mutations in early hematopoietic cells of CLL patients.
Damm F; Mylonas E; Cosson A; Yoshida K; Della Valle V; Mouly E; Diop M; Scourzic L; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Kikushige Y; Davi F; Lambert J; Gautheret D; Merle-Béral H; Sutton L; Dessen P; Solary E; Akashi K; Vainchenker W; Mercher T; Droin N; Ogawa S; Nguyen-Khac F; Bernard OA
Cancer Discov; 2014 Sep; 4(9):1088-101. PubMed ID: 24920063
[TBL] [Abstract][Full Text] [Related]
28. SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.
Cusan M; Shen H; Zhang B; Liao A; Yang L; Jin M; Fernandez M; Iyer P; Wu Y; Hart K; Gutierrez C; Nik S; Pruett-Miller SM; Stark J; Obeng EA; Bowman TV; Wu CJ; Lin RJ; Wang L
J Clin Invest; 2023 Sep; 133(17):. PubMed ID: 37463047
[TBL] [Abstract][Full Text] [Related]
29. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
30. The protein landscape of chronic lymphocytic leukemia.
Meier-Abt F; Lu J; Cannizzaro E; Pohly MF; Kummer S; Pfammatter S; Kunz L; Collins BC; Nadeu F; Lee KS; Xue P; Gwerder M; Roiss M; Hüllein J; Scheinost S; Dietrich S; Campo E; Huber W; Aebersold R; Zenz T
Blood; 2021 Dec; 138(24):2514-2525. PubMed ID: 34189564
[TBL] [Abstract][Full Text] [Related]
31. New boys in town: prognostic role of SF3B1, NOTCH1 and other cryptic alterations in chronic lymphocytic leukemia and how it works.
Filip AA
Leuk Lymphoma; 2013 Sep; 54(9):1876-81. PubMed ID: 23343182
[TBL] [Abstract][Full Text] [Related]
32. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
34. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
35. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
Strefford JC; Sutton LA; Baliakas P; Agathangelidis A; Malčíková J; Plevova K; Scarfó L; Davis Z; Stalika E; Cortese D; Cahill N; Pedersen LB; di Celle PF; Tzenou T; Geisler C; Panagiotidis P; Langerak AW; Chiorazzi N; Pospisilova S; Oscier D; Davi F; Belessi C; Mansouri L; Ghia P; Stamatopoulos K; Rosenquist R
Leukemia; 2013 Nov; 27(11):2196-9. PubMed ID: 23558524
[TBL] [Abstract][Full Text] [Related]
36. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
37. TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Dreger P; Schnaiter A; Zenz T; Böttcher S; Rossi M; Paschka P; Bühler A; Dietrich S; Busch R; Ritgen M; Bunjes D; Zeis M; Stadler M; Uharek L; Scheid C; Hegenbart U; Hallek M; Kneba M; Schmitz N; Döhner H; Stilgenbauer S
Blood; 2013 Apr; 121(16):3284-8. PubMed ID: 23435461
[TBL] [Abstract][Full Text] [Related]
38. Somatic
Foy A; McMullin MF
J Clin Pathol; 2019 Nov; 72(11):778-782. PubMed ID: 31473630
[TBL] [Abstract][Full Text] [Related]
39. Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of
Cavallini C; Visco C; Putta S; Rossi D; Mimiola E; Purvis N; Lovato O; Perbellini O; Falisi E; Facco M; Trentin L; Romanelli MG; Semenzato G; Ambrosetti A; Gaidano G; Pizzolo G; Cesano A; Scupoli MT
Haematologica; 2017 Apr; 102(4):e144-e147. PubMed ID: 27927769
[No Abstract] [Full Text] [Related]
40. Chronic lymphocytic leukemia with SF3B1 mutation.
Quesada V; Ramsay AJ; Lopez-Otin C
N Engl J Med; 2012 Jun; 366(26):2530. PubMed ID: 22738114
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
